The Phylum Bryozoa: From Biology to Biomedical Potential.

Autor: Ciavatta ML; Consiglio Nazionale delle Ricerche (CNR), Istituto di Chimica Biomolecolare (ICB), Via Campi Flegrei 34, 80078 Pozzuoli, Italy., Lefranc F; Service de Neurochirurgie, Hôpital Erasme, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium., Vieira LM; Departamento de Zoologia, Centro de Biociências, Universidade Federal de Pernambuco, Recife, PE 50670-901, Brazil., Kiss R; Retired - formerly at the Fonds National de la Recherche Scientifique (FRS-FNRS), 1000 Brussels, Belgium., Carbone M; Consiglio Nazionale delle Ricerche (CNR), Istituto di Chimica Biomolecolare (ICB), Via Campi Flegrei 34, 80078 Pozzuoli, Italy., van Otterlo WAL; Department of Chemistry and Polymer Science, University of Stellenbosch, Private Bag X1, Matieland 7602, South Africa., Lopanik NB; School of Earth and Atmospheric Sciences, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA., Waeschenbach A; Life Sciences, Natural History Museum, Cromwell Road, London SW7 5BD, UK.
Jazyk: angličtina
Zdroj: Marine drugs [Mar Drugs] 2020 Apr 09; Vol. 18 (4). Date of Electronic Publication: 2020 Apr 09.
DOI: 10.3390/md18040200
Abstrakt: Less than one percent of marine natural products characterized since 1963 have been obtained from the phylum Bryozoa which, therefore, still represents a huge reservoir for the discovery of bioactive metabolites with its ~6000 described species. The current review is designed to highlight how bryozoans use sophisticated chemical defenses against their numerous predators and competitors, and which can be harbored for medicinal uses. This review collates all currently available chemoecological data about bryozoans and lists potential applications/benefits for human health. The core of the current review relates to the potential of bryozoan metabolites in human diseases with particular attention to viral, brain, and parasitic diseases. It additionally weighs the pros and cons of total syntheses of some bryozoan metabolites versus the synthesis of non-natural analogues, and explores the hopes put into the development of biotechnological approaches to provide sustainable amounts of bryozoan metabolites without harming the natural environment.
Databáze: MEDLINE